Comparison of HLA allelic imputation programs
- PMID: 28207879
- PMCID: PMC5312875
- DOI: 10.1371/journal.pone.0172444
Comparison of HLA allelic imputation programs
Abstract
Imputation of human leukocyte antigen (HLA) alleles from SNP-level data is attractive due to importance of HLA alleles in human disease, widespread availability of genome-wide association study (GWAS) data, and expertise required for HLA sequencing. However, comprehensive evaluations of HLA imputations programs are limited. We compared HLA imputation results of HIBAG, SNP2HLA, and HLA*IMP:02 to sequenced HLA alleles in 3,265 samples from BioVU, a de-identified electronic health record database coupled to a DNA biorepository. We performed four-digit HLA sequencing for HLA-A, -B, -C, -DRB1, -DPB1, and -DQB1 using long-read 454 FLX sequencing. All samples were genotyped using both the Illumina HumanExome BeadChip platform and a GWAS platform. Call rates and concordance rates were compared by platform, frequency of allele, and race/ethnicity. Overall concordance rates were similar between programs in European Americans (EA) (0.975 [SNP2HLA]; 0.939 [HLA*IMP:02]; 0.976 [HIBAG]). SNP2HLA provided a significant advantage in terms of call rate and the number of alleles imputed. Concordance rates were lower overall for African Americans (AAs). These observations were consistent when accuracy was compared across HLA loci. All imputation programs performed similarly for low frequency HLA alleles. Higher concordance rates were observed when HLA alleles were imputed from GWAS platforms versus the HumanExome BeadChip, suggesting that high genomic coverage is preferred as input for HLA allelic imputation. These findings provide guidance on the best use of HLA imputation methods and elucidate their limitations.
Conflict of interest statement
Figures



Similar articles
-
Significant variation between SNP-based HLA imputations in diverse populations: the last mile is the hardest.Pharmacogenomics J. 2018 May 22;18(3):367-376. doi: 10.1038/tpj.2017.7. Epub 2017 Apr 25. Pharmacogenomics J. 2018. PMID: 28440342 Free PMC article.
-
Performance of HLA allele prediction methods in African Americans for class II genes HLA-DRB1, -DQB1, and -DPB1.BMC Genet. 2014 Jun 16;15:72. doi: 10.1186/1471-2156-15-72. BMC Genet. 2014. PMID: 24935557 Free PMC article.
-
HIBAG--HLA genotype imputation with attribute bagging.Pharmacogenomics J. 2014 Apr;14(2):192-200. doi: 10.1038/tpj.2013.18. Epub 2013 May 28. Pharmacogenomics J. 2014. PMID: 23712092 Free PMC article.
-
Human leucocyte antigen class I and II imputation in a multiracial population.Int J Immunogenet. 2016 Dec;43(6):369-375. doi: 10.1111/iji.12292. Epub 2016 Oct 24. Int J Immunogenet. 2016. PMID: 27774761 Free PMC article.
-
Tutorial: a statistical genetics guide to identifying HLA alleles driving complex disease.Nat Protoc. 2023 Sep;18(9):2625-2641. doi: 10.1038/s41596-023-00853-4. Epub 2023 Jul 26. Nat Protoc. 2023. PMID: 37495751 Free PMC article. Review.
Cited by
-
Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions.Annu Rev Pharmacol Toxicol. 2019 Jan 6;59:463-486. doi: 10.1146/annurev-pharmtox-010818-021818. Epub 2018 Aug 22. Annu Rev Pharmacol Toxicol. 2019. PMID: 30134124 Free PMC article. Review.
-
Human Leukocyte Antigen B*14:01 and B*35:01 Are Associated With Trimethoprim-Sulfamethoxazole Induced Liver Injury.Hepatology. 2021 Jan;73(1):268-281. doi: 10.1002/hep.31258. Hepatology. 2021. PMID: 32270503 Free PMC article.
-
Fine mapping of the HLA locus in Parkinson's disease in Europeans.NPJ Parkinsons Dis. 2021 Sep 21;7(1):84. doi: 10.1038/s41531-021-00231-5. NPJ Parkinsons Dis. 2021. PMID: 34548497 Free PMC article.
-
Machine learning models for pharmacogenomic variant effect predictions - recent developments and future frontiers.Pharmacogenomics. 2025 Apr-Apr;26(5-6):171-182. doi: 10.1080/14622416.2025.2504863. Epub 2025 May 22. Pharmacogenomics. 2025. PMID: 40401639 Review.
-
Assessing HLA imputation accuracy in a West African population.bioRxiv [Preprint]. 2023 Jan 23:2023.01.23.525129. doi: 10.1101/2023.01.23.525129. bioRxiv. 2023. Update in: PLoS One. 2023 Sep 28;18(9):e0291437. doi: 10.1371/journal.pone.0291437. PMID: 36747714 Free PMC article. Updated. Preprint.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous